Benjamin Sadacca
Benjamin Sadacca
1Residual Tumor & Response to Treatment Laboratory (RT2Lab), PSL Research University, Translational Research Department, F-75248 Paris, France
2U932 Immunity and Cancer; INSERM; Institut Curie, Paris, France
3Laboratoire de Mathématiques et Modélisation d’Evry, Université d’Évry Val d’Essonne, UMR CNRS 8071, ENSIIE, USC INRA, Evry, Val d’Essonne France
1,2,3,
Anne-Sophie Hamy
Anne-Sophie Hamy
1Residual Tumor & Response to Treatment Laboratory (RT2Lab), PSL Research University, Translational Research Department, F-75248 Paris, France
2U932 Immunity and Cancer; INSERM; Institut Curie, Paris, France
1,2,
Cécile Laurent
Cécile Laurent
1Residual Tumor & Response to Treatment Laboratory (RT2Lab), PSL Research University, Translational Research Department, F-75248 Paris, France
2U932 Immunity and Cancer; INSERM; Institut Curie, Paris, France
1,2,
Pierre Gestraud
Pierre Gestraud
5Institut Curie, PSL Research University, Mines Paris Tech, Bioinformatics and Computational Systems Biology of Cancer, INSERM U900, F-75005 Paris, France
5,
Hélène Bonsang-Kitzis
Hélène Bonsang-Kitzis
1Residual Tumor & Response to Treatment Laboratory (RT2Lab), PSL Research University, Translational Research Department, F-75248 Paris, France
2U932 Immunity and Cancer; INSERM; Institut Curie, Paris, France
6Department of Surgery, Institut Curie, Paris, F-75248 France
1,2,6,
Alice Pinheiro
Alice Pinheiro
1Residual Tumor & Response to Treatment Laboratory (RT2Lab), PSL Research University, Translational Research Department, F-75248 Paris, France
2U932 Immunity and Cancer; INSERM; Institut Curie, Paris, France
1,2,
Judith Abecassis
Judith Abecassis
1Residual Tumor & Response to Treatment Laboratory (RT2Lab), PSL Research University, Translational Research Department, F-75248 Paris, France
2U932 Immunity and Cancer; INSERM; Institut Curie, Paris, France
4Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, F-77300 France
5Institut Curie, PSL Research University, Mines Paris Tech, Bioinformatics and Computational Systems Biology of Cancer, INSERM U900, F-75005 Paris, France
1,2,4,5,
Pierre Neuvial
Pierre Neuvial
3Laboratoire de Mathématiques et Modélisation d’Evry, Université d’Évry Val d’Essonne, UMR CNRS 8071, ENSIIE, USC INRA, Evry, Val d’Essonne France
7Institut de Mathématiques de Toulouse; UMR5219 Université de Toulouse; CNRS UPS IMT, F-31062 Toulouse Cedex 9, France
3,7,
Fabien Reyal
Fabien Reyal
1Residual Tumor & Response to Treatment Laboratory (RT2Lab), PSL Research University, Translational Research Department, F-75248 Paris, France
2U932 Immunity and Cancer; INSERM; Institut Curie, Paris, France
6Department of Surgery, Institut Curie, Paris, F-75248 France
1,2,6,✉
1Residual Tumor & Response to Treatment Laboratory (RT2Lab), PSL Research University, Translational Research Department, F-75248 Paris, France
2U932 Immunity and Cancer; INSERM; Institut Curie, Paris, France
3Laboratoire de Mathématiques et Modélisation d’Evry, Université d’Évry Val d’Essonne, UMR CNRS 8071, ENSIIE, USC INRA, Evry, Val d’Essonne France
4Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, F-77300 France
5Institut Curie, PSL Research University, Mines Paris Tech, Bioinformatics and Computational Systems Biology of Cancer, INSERM U900, F-75005 Paris, France
6Department of Surgery, Institut Curie, Paris, F-75248 France
7Institut de Mathématiques de Toulouse; UMR5219 Université de Toulouse; CNRS UPS IMT, F-31062 Toulouse Cedex 9, France
© The Author(s) 2018
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
